Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 53

Sort by

Sort Order Select

Journal Articles

Comprehensive Characterization of the Cell States and Ecosystems in Classic Hodgkin Lymphoma Using Single-Cell RNA-Seq, Digital Deconvolution, and Machine Learning

Shengqin Su, Ajay Subramanian, Timothy Flerlage, Jamie E. Flerlage, Cedric Rossi, Troy Noordenbos, Joseph G. Schroers-Martin, Everett J. Moding, Richard T. Hoppe, Ranjana H. Advani, Yasodha Natkunam, Ash A. Alizadeh, Michael S. Binkley

Blood (2024) 144 (Supplement 1): 4369.

https://doi.org/10.1182/blood-2024-212013

Published: 2024

Journal Articles

Pembrolizumab for Front-Line Treatment of Extranodal NK/T-Cell Lymphoma

Blood (2024) 144 (Supplement 1): 3068.

https://doi.org/10.1182/blood-2024-206398

Published: 2024

Journal Articles

Investigating Treatment Kinetics and Local Response during and after Bridging Radiotherapy Prior to CAR-T Cell Therapy for Lymphomas

Daniella Klebaner, Natalie Park, Mallika Marar, Matthew J. Frank, Susan Hiniker, Richard T. Hoppe, Joseph G. Schroers-Martin, Ranjana H. Advani, Ash A. Alizadeh, Sushma Bharadwaj, David B. Miklos, Saurabh Dahiya, Michael S. Binkley

Blood (2024) 144 (Supplement 1): 7130.

https://doi.org/10.1182/blood-2024-200930

Published: 2024

Journal Articles

A Standard Operating Protocol for Pre-Transplant Low Dose Splenic Radiotherapy for Patients with Myelofibrosis

Claire Baniel, Natalie Park, Daniella Klebaner, William Shomali, Jason Gotlib, Sally Arai, Susan Hiniker, Richard T. Hoppe, Laura Johnston, Michael S. Binkley

Blood (2024) 144 (Supplement 1): 2116.

https://doi.org/10.1182/blood-2024-206503

Published: 2024

Journal Articles

Development and Validation of the Early-Stage Hodgkin Lymphoma (HL) International Prognostication Index (E-HIPI): A Report from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium

Andrew M Evens, Angie Mae Rodday, Matthew J. Maurer, Ranjana H. Advani, Marc Andre, Andrea Gallamini, Annette E. Hay, David Hodgson, Richard T. Hoppe, Martin Hutchings, Peter Johnson, Brian K. Link, Stephen Opat, John M. Raemaekers, Jenica Upshaw, Qingyan Xiang, Nicholas Counsell, Susan K Parsons, John Radford

Blood (2023) 142 (Supplement 1): 3058.

https://doi.org/10.1182/blood-2023-173320

Published: 2023

Journal Articles

Investigating the Cell States and Prognostic Impact of Tumor Microenvironment Ecosystems in Classic Hodgkin Lymphoma

Shengqin Su, Ajay Subramanian, Timothy Flerlage, Jamie E. Flerlage, Stefan K. Alig, Everett J. Moding, Richard T. Hoppe, Ranjana H. Advani, Yasodha Natkunam, Ash A. Alizadeh, Michael S. Binkley

Blood (2023) 142 (Supplement 1): 3016.

https://doi.org/10.1182/blood-2023-180288

Published: 2023

Journal Articles

Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents

Michael A. Spinner, R. A. Sica, John S. Tamaresis, Ying Lu, Cheryl Chang, Robert Lowsky, Matthew J. Frank, Laura J. Johnston, David B. Miklos, Lori S. Muffly, Robert S. Negrin, Andrew R. Rezvani, Parveen Shiraz, Judith A. Shizuru, Wen-Kai Weng, Michael S. Binkley, Richard T. Hoppe, Ranjana H. Advani, Sally Arai

Blood (2023) 141 (22): 2727–2737.

https://doi.org/10.1182/blood.2022018827

Published: 2023

Includes: Supplemental data

Journal Articles

Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG

Blood (2020) 135 (26): 2365–2374.

https://doi.org/10.1182/blood.2019003877

Published: 2020

Includes: Supplemental data

Journal Articles

A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma

Blood (2019) 134 (Supplement_1): 2834.

https://doi.org/10.1182/blood-2019-123150

Published: 2019

Journal Articles

Definitive radiotherapy for localized follicular lymphoma staged by 18 F-FDG PET-CT: a collaborative study by ILROG

Blood (2019) 133 (3): 237–245.

https://doi.org/10.1182/blood-2018-04-843540

Published: 2019

Includes: Supplemental data

Journal Articles

No Utility of Routine Laboratory Testing during Surveillance in Detecting Relapse in Patients with Classic Hodgkin Lymphoma in First Remission

Ryan C. Lynch, MD, Vandana Sundaram, MPH, Manisha Desai, PhD, Solomon Henry, MS, Douglas Wood, MS, Sarah Daadi, Karen S. Corbelli, Saul Rosenberg, MD, Richard T Hoppe, MD, Ranjana Advani, MD

Blood (2018) 132 (Supplement 1): 615.

https://doi.org/10.1182/blood-2018-99-113156

Published: 2018

Journal Articles

Nonmyeloablative Allogeneic Transplantation Using TLI-ATG Conditioning for Lymphoid and Myeloid Malignancies: Mature Follow-up from a Large, Single Institution Cohort

Michael A Spinner, MD, Vanessa E Kennedy, MD, John S Tamaresis, PhD, Philip W Lavori, PhD, Linda V Elder, BA, Sally Arai, MD, Laura J Johnston, MD, Everett H Meyer, MD PhD, David B. Miklos, MD PhD, Lori S Muffly, MD, Robert S. Negrin, MD, Andrew R Rezvani, MD, Judith A Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Richard T Hoppe, MD, Samuel Strober, MD, Robert Lowsky, MD

Blood (2018) 132 (Supplement 1): 4638.

https://doi.org/10.1182/blood-2018-99-113597

Published: 2018

Journal Articles

A Pilot Study of Brentuximab Vedotin and AVD Chemotherapy Followed By 20 Gy Involved-Site Radiotherapy in Early Stage, Unfavorable Risk Hodgkin Lymphoma

Blood (2017) 130 (Supplement 1): 734.

https://doi.org/10.1182/blood.V130.Suppl_1.734.734

Published: 2017

Journal Articles

Utility of Systemic Staging in Low Grade B-Cell Lymphomas Presenting in the Skin

Meenal Kheterpal, MD, Shamir Geller, MD, Julia Dai, MD, Melissa Pulitzer, MD, Patricia Myskowski, MD, Alison J. Moskowitz, MD, Jinah Kim, MD PhD, Richard T. Hoppe, MD, Youn H. Kim, MD, Steven M. Horwitz, MD

Blood (2017) 130 (Supplement 1): 2774.

https://doi.org/10.1182/blood.V130.Suppl_1.2774.2774

Published: 2017

Journal Articles

A Single-Arm PHASE 2A Study of NM-IL-12 (rHu-IL12) in Patients with Mycosis Fungoides-Type CTCL (MF) Undergoing Low-Dose TOTAL Skin Electron BEAM Therapy (LD-TSEBT)

Youn H Kim, MD, Richard T. Hoppe, MD, Alain H Rook, MD, Amit Maity, MD PhD, Larisa J Geskin, MD, David P Horowitz, MD, Genet Finnegan, MHS, PA-C, Michael Khodadoust, MD PhD, Wen-Kai Weng, MD PhD, Analuisa Lares, ANP, BSN, RN, Eric Ki Jun Hong, BS, Marie Buchanan, RN, Vernon Ma, BS, Hue Kha, BS, Chris E Lawrence, PhD, Vladimir Vainstein, MD, Lena A Basile, PhD JD

Blood (2016) 128 (22): 4165.

https://doi.org/10.1182/blood.V128.22.4165.4165

Published: 2016

Journal Articles

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

Margaretha GM Roemer, MS, Ranjana H Advani, MD, Azra H. Ligon, PhD, Yasodha Natkunam, MD PhD, Robert A Redd, MS, Heather Homer, Courtney Connelly, Heather H. Sun, Sarah E. Daadi, Bjoern Chapuy, MD PhD, Daphne de Jong, MD PhD, Richard T. Hoppe, MD, Donna S Neuberg, ScD, Scott J Rodig, MD PhD, Margaret A. Shipp, MD

Blood (2015) 126 (23): 176.

https://doi.org/10.1182/blood.V126.23.176.176

Published: 2015

Journal Articles

Dose-Escalated, Intratumoral TLR9 Agonist and Low-Dose Radiation Induce Abscopal Effects in Follicular Lymphoma

Holbrook E Kohrt, MD PhD, Jaqueline Chu, MD, Joshua Brody, MD, Debra K Czerwinski, Cariad Chester, Mohith Sadaram, BS, Ranjana Advani, MD, Youn H. Kim, MD, Richard T. Hoppe, MD, Susan J. Knox, MD PhD, Irene Wapnir, MD, Robert J. Tibshirani, PhD, Ron Levy, MD

Blood (2014) 124 (21): 3092.

https://doi.org/10.1182/blood.V124.21.3092.3092

Published: 2014

Journal Articles

Use of High-Throughput Sequencing (HTS) of TCRß to Determine the Kinetics of Graft-Versus-Lymphoma (GVL) Effect and T-Cell Repertoire Profiles after Allogeneic Transplant

Wen-Kai Weng, MD PhD, Randall Armstrong, Sally Arai, MD, Richard T. Hoppe, MD, Everett H. Meyer, MD PhD, Youn H. Kim, MD

Blood (2014) 124 (21): 2473.

https://doi.org/10.1182/blood.V124.21.2473.2473

Published: 2014

Journal Articles

Non-Myeloablative Allogeneic Transplantation Resulting in Clinical and Molecular Remission with Low Non-Relapse Mortality (NRM) in Patients with Advanced Stage Mycosis Fungoides (MF) and Sézary Syndrome (SS)

Wen-Kai Weng, MD PhD, Randall Armstrong, Sally Arai, MD, Laura Johnston, MD, Ginna G. Laport, MD, Robert Lowsky, MD, David B. Miklos, Judith A. Shizuru, MD PhD, Jonathan E. Benjamin, Robert S. Negrin, MD, Sunil Reddy, MD, Lynn Million, MD, Richard T. Hoppe, MD, Youn H. Kim, MD

Blood (2014) 124 (21): 2544.

https://doi.org/10.1182/blood.V124.21.2544.2544

Published: 2014

Journal Articles

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides or Sezary Syndrome: Final Results Show Significant Clinical Activity and Suggest Correlation with CD30 Expression

Youn H. Kim, MD, Mahkam Tavallaee, MD MPH, Sima Rozati, MD, Uma Sundram, MD PhD, Katrin Salva, MD, Gary S. Wood, MD, Shufeng Li, MS, Michael Krathen, MD, Seema Nagpal, MD, Sunil Reddy, MD, Randall Armstrong, Richard T. Hoppe, MD, Melissa Pulitzer, MD, Ranjana H Advani, MD, Steven M. Horwitz, MD

Blood (2014) 124 (21): 804.

https://doi.org/10.1182/blood.V124.21.804.804

Published: 2014

NARROW

Comprehensive Characterization of the Cell States and Ecosystems in Classic Hodgkin Lymphoma Using Single-Cell RNA-Seq, Digital Deconvolution, and Machine Learning

Pembrolizumab for Front-Line Treatment of Extranodal NK/T-Cell Lymphoma

Investigating Treatment Kinetics and Local Response during and after Bridging Radiotherapy Prior to CAR-T Cell Therapy for Lymphomas

A Standard Operating Protocol for Pre-Transplant Low Dose Splenic Radiotherapy for Patients with Myelofibrosis

Development and Validation of the Early-Stage Hodgkin Lymphoma (HL) International Prognostication Index (E-HIPI): A Report from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium

Investigating the Cell States and Prognostic Impact of Tumor Microenvironment Ecosystems in Classic Hodgkin Lymphoma

Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents

Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG

A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma

Definitive radiotherapy for localized follicular lymphoma staged by 18 F-FDG PET-CT: a collaborative study by ILROG

No Utility of Routine Laboratory Testing during Surveillance in Detecting Relapse in Patients with Classic Hodgkin Lymphoma in First Remission

Nonmyeloablative Allogeneic Transplantation Using TLI-ATG Conditioning for Lymphoid and Myeloid Malignancies: Mature Follow-up from a Large, Single Institution Cohort

A Pilot Study of Brentuximab Vedotin and AVD Chemotherapy Followed By 20 Gy Involved-Site Radiotherapy in Early Stage, Unfavorable Risk Hodgkin Lymphoma

Utility of Systemic Staging in Low Grade B-Cell Lymphomas Presenting in the Skin

A Single-Arm PHASE 2A Study of NM-IL-12 (rHu-IL12) in Patients with Mycosis Fungoides-Type CTCL (MF) Undergoing Low-Dose TOTAL Skin Electron BEAM Therapy (LD-TSEBT)

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

Dose-Escalated, Intratumoral TLR9 Agonist and Low-Dose Radiation Induce Abscopal Effects in Follicular Lymphoma

Use of High-Throughput Sequencing (HTS) of TCRß to Determine the Kinetics of Graft-Versus-Lymphoma (GVL) Effect and T-Cell Repertoire Profiles after Allogeneic Transplant

Non-Myeloablative Allogeneic Transplantation Resulting in Clinical and Molecular Remission with Low Non-Relapse Mortality (NRM) in Patients with Advanced Stage Mycosis Fungoides (MF) and Sézary Syndrome (SS)

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides or Sezary Syndrome: Final Results Show Significant Clinical Activity and Suggest Correlation with CD30 Expression

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only